The Anti-CSPG4 Chimeric Recombinant Rabbit Monoclonal Antibody (HDAB0292) is a cutting-edge tool for researchers studying CSPG4, a cell surface glycoprotein involved in various physiological and pathological processes. This highly specific antibody, developed using advanced chimeric recombinant technology, allows for precise and reliable detection of CSPG4 in human samples.With its high reactivity and specificity, this antibody is an ideal choice for applications such as immunohistochemistry, immunofluorescence, and flow cytometry. Its ability to bind specifically to CSPG4 enables researchers to accurately analyze the expression and localization of this protein in a variety of cell types and tissues.
CSPG4, also known as NG2, is known to play a critical role in processes such as cell proliferation, migration, and invasion, making it a valuable target for cancer research and other related fields. By using the Anti-CSPG4 Chimeric Recombinant Rabbit Monoclonal Antibody, researchers can gain valuable insights into the function and regulation of CSPG4, ultimately leading to advancements in the understanding and treatment of various diseases, including cancer.
Purified from cell culture supernatant by affinity chromatography
Formulation:
Powder
Buffer:
1XPBS
Storage:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Usage:
Research use only
Background:
A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells. [provided by RefSeq, Jul 2008]
